SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-009637
Filing Date
2020-08-06
Accepted
2020-08-06 16:05:22
Documents
97
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20200630x10q.htm   iXBRL 10-Q 2489053
2 EX-31.1 irwd-20200630xex31d1.htm EX-31.1 16890
3 EX-31.2 irwd-20200630xex31d2.htm EX-31.2 16935
4 EX-32.1 irwd-20200630xex32d1.htm EX-32.1 8008
5 EX-32.2 irwd-20200630xex32d2.htm EX-32.2 8014
  Complete submission text file 0001558370-20-009637.txt   10563043

Data Files

Seq Description Document Type Size
6 EX-101.SCH irwd-20200630.xsd EX-101.SCH 82199
7 EX-101.CAL irwd-20200630_cal.xml EX-101.CAL 78202
8 EX-101.DEF irwd-20200630_def.xml EX-101.DEF 382225
9 EX-101.LAB irwd-20200630_lab.xml EX-101.LAB 623311
10 EX-101.PRE irwd-20200630_pre.xml EX-101.PRE 621571
11 EXTRACTED XBRL INSTANCE DOCUMENT irwd-20200630x10q_htm.xml XML 1874131
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 201081539
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences